Company Filing History:
Years Active: 2004-2023
Title: Bruce Randazzo: Innovator in Medical Treatments
Introduction
Bruce Randazzo is a notable inventor based in Rydal, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of psoriasis and type II diabetes. With a total of 2 patents, his work reflects a commitment to improving patient outcomes through innovative therapies.
Latest Patents
Randazzo's latest patents include a safe and effective method of treating psoriasis with an anti-IL-23 specific antibody. This method involves administering an IL-23 specific antibody, such as guselkumab, in a clinically proven safe and effective amount. The treatment aims for the patient to achieve PASI90, PASI100, or IGA 0 or 1 scores as measured at various intervals after the initial treatment. Additionally, he has developed a combination therapy for type II diabetes or Syndrome X. This invention outlines methods for using a pharmacological combination of biguanide agents, like metformin, along with PTPase inhibiting agents and optional sulfonlylurea agents to treat metabolic disorders related to insulin resistance or hyperglycemia.
Career Highlights
Throughout his career, Randazzo has worked with prominent companies such as Wyeth and Janssen Biotech, Inc. His experience in these organizations has contributed to his expertise in developing innovative medical treatments.
Collaborations
Randazzo has collaborated with notable coworkers, including Philippe John Robert Vitou and John Thomas Gwynne. These partnerships have likely enhanced his research and development efforts in the medical field.
Conclusion
Bruce Randazzo's contributions to medical innovation, particularly in treating psoriasis and type II diabetes, highlight his role as a significant inventor. His patents reflect a dedication to advancing healthcare solutions for patients.